HomeExpert Team Expert Team

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.
Filter Providers By
Expert Team
Filter Providers By
Close
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 1
  • 2
  • 3
  • 4
  • 5
Filter Providers By
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Lv Yue
    Lv Yue
    Expert in the diagnosis and treatment of leukemia, lymphoma, multiple myeloma, MDS, and complex metastatic tumors; possesses profound expertise and extensive clinical experience in the field of hematologic oncology.
    Profile:
    Fosun Cancer Hospital Guangzhou, Lü Yue, Chief Physician of Oncology Ward 1 at Guangzhou Fosun Chancheng Hospital and renowned hematologic oncology expert. Formerly the Director and Academic Leader of the Department of Hematologic Oncology at Sun Yat-sen University Cancer Center; holds an M.D. and serves as a doctoral supervisor. Specializes in the diagnosis and treatment of hematologic malignancies such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes (MDS); possesses extensive experience in the comprehensive treatment of complex and metastatic tumors.
  • Peng Qirong
    Peng Qirong
    Specializes in minimally invasive interventional procedures, seed implantation, ablation, and hyperthermia for malignant tumors such as liver, lung, esophageal, and gastric cancers; possesses extensive experience in the minimally invasive diagnosis and treatment of digestive system tumors.
    Profile:
    Fosun Cancer Hospital Guangzhou, Peng Qirong, Director of Oncology Ward 1 and Associate Chief Physician at Guangzhou Fosun Chancheng Hospital. Formerly the Director of Oncology, Radiotherapy, and the Liver Cancer Center at PLA Hospital No. 458. He has long specialized in minimally invasive diagnosis and treatment of tumors, with expertise in minimally invasive interventional procedures, seed implantation, ablation, and hyperthermia for malignancies such as liver, lung, esophageal, and gastric cancers.
  • Ye Gang
    Ye Gang
    Possesses over 30 years of clinical experience in the US and China; specializes in various cancers and hematological disorders, with profound expertise in the diagnosis and treatment of breast cancer, lung cancer, lymphoma, and multiple myeloma, as well as extensive experience in the clinical application of innovative drugs.
    Profile:
    Fosun Cancer Hospital Guangzhou, Ye Gang, Chief Expert and Discipline Leader of Medical Oncology at the Center for Precision Diagnosis and Treatment of Tumors, Foshan Fosun Chancheng Hospital; licensed physician in the US (Internal Medicine, Hematology, and Medical Oncology); over 30 years of clinical experience in the US and China; specializes in the diagnosis and treatment of breast cancer, lung cancer, lymphoma, and multiple myeloma.
  • Luo Pengfei
    Luo Pengfei
    A pioneer of interventional oncology (radiology) in my country; specializes in interventional therapy for solid tumors such as liver, lung, pancreatic, and cholangiocarcinoma, as well as head and neck cancers and bone metastases, achieving significant therapeutic effects in severe, advanced-stage malignancies.
    Profile:
    Fosun Cancer Hospital Guangzhou — Luo Pengfei. Chief Physician, Oncology Department (Ward 5), Guangzhou Fosun Chancheng Hospital; Lifetime Professor, Guangdong Provincial People's Hospital; Adjunct Professor, Sun Yat-sen University. A renowned expert in interventional oncology and interventional radiology in my country, he has over 40 years of experience in the field. He specializes in interventional treatments for solid tumors—including liver, lung, pancreatic, and cholangiocarcinoma, as well as head and neck cancers and bone metastases—and possesses extensive experience in the comprehensive treatment of advanced-stage tumors.
  • Lu Qiuxia
    Lu Qiuxia
    Specializes in the diagnosis and comprehensive treatment—including precision radiotherapy, combined radiochemotherapy, molecular targeted therapy, and cellular immunobiotherapy—of various benign and malignant tumors.Possesses extensive experience in the precision diagnosis and treatment of nasopharyngeal carcinoma, head and neck tumors, lung cancer, and intracranial tumors, with particular expertise in the clinical application of CyberKnife technology.
    Profile:
    Fosun Cancer Hospital Guangzhou, Lu Qiuxia, Medical Director of the Precision Oncology Center, Head of the Precision Radiotherapy Center, and Lead for Sino-US MDT at Foshan Fosun Chancheng Hospital. With over 20 years of experience in radiation oncology, she specializes in precision radiotherapy, combined radiochemotherapy, and CyberKnife treatment, possessing extensive expertise in the diagnosis and treatment of nasopharyngeal carcinoma, head and neck tumors, lung cancer, and intracranial tumors.
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 1
  • 2
  • 3
  • 4
  • 5

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.